Corazones Unidos Study
NCT07298213 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2025-12-23
Summary
CVD is the leading cause of death among individuals with MASLD, a risk factor for liver cancer. In Southern Arizona, CVD and cancer (including liver and gastric cancer) are among the leading causes of death for Mexican-origin adults.1 Given Mexican-origin adults' disproportionate burden of CVD-related mortality37 and higher rates of MASLD compared to other ethnic/racial groups; we urgently need to develop contextually tailored strategies for management of CVD risk factors and outcomes. Thus, the purpose of this study is to examine the acceptability and feasibility of a community health worker (CHW)-led intervention aimed to increase cardiovascular risk awareness and promote lifestyle modifications among Mexican-origin adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Southern Arizona region. The proposed project has the potential to improve health outcomes for this vulnerable population and contribute to the ACS-CHERC's overarching goal of improving health equity for Hispanic communities and family caregivers.
Conditions
- CVD - Cardiovascular Disease
- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Interventions
- BEHAVIORAL
-
Your Heart, Your Health
Trained CHWs will facilitate educational sessions where participants will learn about heart-healthy behaviors, heart attack symptoms, heart-healthy eating for Hispanic families, and risk factors for both CVD and MASLD. Participants will also be taught behavioral change techniques including goal setting, problem solving, and relapse prevention. Specifically, participants will be asked to collaborate in selecting specific lifestyle goals and to develop shared strategies for improving adherence to their goals, overcoming barriers, and providing support to address potential relapses. Curriculum content will be supplemented by a variety of approaches designed to motivate behavior change including videos, role play, and low-literacy culturally appropriate brochures published by NHLBI.
Sponsors & Collaborators
-
University of Arizona
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-18
- Primary Completion
- 2026-07-17
- Completion
- 2026-07-17
Countries
- United States
Study Locations
More Related Trials
-
Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
NCT04132440 ·Status: ACTIVE_NOT_RECRUITING
-
Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes
NCT07270822 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)
NCT03613480 ·Status: UNKNOWN ·Phase: NA
-
Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH
NCT05357248 ·Status: COMPLETED ·Phase: NA
-
A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
NCT05395481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease
NCT05754385 ·Status: COMPLETED ·Phase: NA
-
Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease
NCT04988204 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.
NCT06750276 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis
NCT02051842 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4
NCT07052682 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis
NCT05065593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)
NCT05292911 ·Status: COMPLETED ·Phase: PHASE1
-
Quantifying Hepatic Mitochondrial Fluxes in Humans
NCT05305287 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
NCT06836609 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NCT06138821 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT05006885 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients
NCT06503068 ·Status: RECRUITING
-
Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease
NCT04031729 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees
NCT06536933 ·Status: NOT_YET_RECRUITING
-
Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
NCT07188220 ·Status: RECRUITING
-
Treatment of Non Alcoholic Fatty Liver Disease With Lifestyle Modification and Acupuncture
NCT02006329 ·Status: UNKNOWN ·Phase: NA
-
Comparing Effects of Beetroot Juice and Mediterranean Diet on Liver Enzymes and Sonography in Patients With NAFLD
NCT05909631 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
NCT06934642 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Assessment of Non-Invasive Testing in Major Liver-Related Outcomes
NCT06986447 ·Status: ENROLLING_BY_INVITATION